Low incidence of neurological recurrent side effects following COVID-19 reimmunization
QJM
.
2023 Dec 27;116(12):1039.
doi: 10.1093/qjmed/hcad153.
Authors
J S Koh
1
,
A R Cook
2
,
R C S Seet
3
4
5
Affiliations
1
Department of Neurology, National Neuroscience Institute (Tan Tock Seng Hospital Campus), Singapore.
2
Saw Swee Hock School of Public Health, National University Singapore and National University Health System, Singapore.
3
Division of Neurology, Department of Medicine, National University Health System, Singapore.
4
Department of Medicine, Yong Loo Lin School of Medicine, National University Singapore, Singapore.
5
Healthy Longevity Translational Research Programme, Yong Loo Lin School of Medicine, National University Singapore, Singapore.
PMID:
37364012
DOI:
10.1093/qjmed/hcad153
No abstract available
MeSH terms
COVID-19* / epidemiology
Humans
Incidence